SCHEMBL17832405

SCHEMBL17832405

CC(=O)c1cncc(-c2[nH]c(-c3ccccc3)nc2-c2n[nH]c(=O)n2C2CC2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.40
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 3/20 0.40
GLA P06280 3/20 0.40
GAA P10253 3/20 0.40
HPGD P15428 3/20 0.40
MEN1 O00255 3/20 0.39
CYP1A2 P05177 1/20 0.37
MAPT P10636 1/20 0.37
CYP2C19 P33261 1/20 0.37
GFER P55789 1/20 0.37
MAPK14 Q16539 6/20 0.37
CSNK1D P48730 2/20 0.37
CSNK1E P49674 2/20 0.37
RAF1 P04049 3/20 0.36
GSK3B P49841 1/20 0.35
NPY5R Q15761 1/20 0.34
MAPK13 O15264 2/20 0.33
MAPK12 P53778 2/20 0.33
MAPK11 Q15759 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL17822996 0.97 KMT2A (0.38) KMT2AKDM4EALDH1A1GLAGAA
SCHEMBL17823083 0.90 KDM4E (0.42) KMT2AKDM4EALDH1A1GLAGAA
Hydrochloric Acid SCHEMBL17823071 0.89 KDM4E (0.41) KMT2AKDM4EALDH1A1GLAGAA
SCHEMBL19715268 0.88 MAPK14 (0.41) KMT2AKDM4EALDH1A1GLAGAA
Hydrochloric Acid SCHEMBL19715283 0.87 MAPK14 (0.40) KMT2AKDM4EALDH1A1GLAGAA
SCHEMBL17823059 0.84 KMT2A (0.40) KMT2AKDM4EALDH1A1GLAGAA
Hydrochloric Acid SCHEMBL19715276 0.83 KMT2A (0.39) KMT2AKDM4EALDH1A1GLAGAA
SCHEMBL17822993 0.83 CHEK2 (0.43) KMT2AKDM4EALDH1A1GLAGAA
SCHEMBL17823092 0.82 LRRK2 (0.42) KMT2AKDM4EALDH1A1GLAGAA
SCHEMBL17823031 0.82 ALDH1A1 (0.39) KMT2AKDM4EALDH1A1GLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107207474-B Substituted heterocycles as bromodomain inhibitors 恒翼生物医药科技(上海)有限公司 2021-05-07 CN claimed
EP-3230277-B1 SUBSTITUTED HETEROCYCLES AS BROMODOMAIN INHIBITORS ZENITH EPIGENETICS LTD (CA) 2019-09-18 EP claimed
CN-107207474-B Substituted heterocycles as bromodomain inhibitors 恒翼生物医药科技(上海)有限公司 2021-05-07 CN disclosed
US-10292968-B2 Substituted heterocycles as bromodomain inhibitors ZENITH EPIGENETICS LTD. (CA) 2019-05-21 US disclosed
US-20170360756-A1 SUBSTITUTED HETEROCYCLES AS BROMODOMAIN INHIBITORS ZENITH EPIGENETICS CORP. (CA) 2017-12-21 US disclosed
US-20170360756-A1 SUBSTITUTED HETEROCYCLES AS BROMODOMAIN INHIBITORS ZENITH EPIGENETICS CORP. (CA) 2017-12-21 US disclosed
WO-2016092375-A1 SUBSTITUTED HETEROCYCLES AS BROMODOMAIN INHIBITORS ZENITH EPIGENETICS CORP. (CA) 2016-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170360756-A1 SUBSTITUTED HETEROCYCLES AS BROMODOMAIN INHIBITORS BRD4, BRD3, BRD1 KMT2A 727/4885KDM4E 524/4885ALDH1A1 3607/4885
US-10292968-B2 Substituted heterocycles as bromodomain inhibitors BRD4, BRD3, BRD1 KMT2A 727/4885KDM4E 524/4885ALDH1A1 3607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.